BIMZELXHCP.COM KEYWORD DENSITY CHECKER

Total words: 4009 | 2-word phrases: 1051 | 3-word phrases: 1185 | 4-word phrases: 1238

PAGE INFO

Title Try to keep the title under 60 characters (60 characters)
BIMZELX® for Moderate-to-Severe Plaque Psoriasis | for HCPs
Description Try to keep the meta description between 50 - 160 characters (159 characters)
Explore BIMZELX®, the first and only approved IL-17A + IL-17F inhibitor. See BIMZELX dosing information, BIMZELX prescribing info, plus BIMZELX clinical data.
Keywords Meta keywords are not recommended anymore (159 characters)
Psoriasis, plaque psoriasis, bimzelx, bimekizumab, skin, clear skin, IL-17A, IL-17F, PASI 90, PASI 100
H1 H1 tag on the page (23 characters)
Utility Navigation Left

ONE WORD PHRASES 535 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1of519.53%
2the509.35%
3and458.41%
4bimzelx295.42%
5with254.67%
6patients244.49%
7for244.49%
8in234.30%
9to213.93%
10a213.93%

TWO WORD PHRASES 1051 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1in patients100.95%
2bimzelx in90.86%
3of the90.86%
4patients with90.86%
5with a80.76%
6from the70.67%
7of bimzelx70.67%
8and be70.67%
9use of60.57%
10of a60.57%
11   60.57%
12clinical trial50.48%
13the be50.48%
14or a50.48%
15with bimzelx50.48%
16prescribing information50.48%
17at week40.38%
18us healthcare40.38%
19the risk40.38%
20treatment with40.38%

THREE WORD PHRASES 1185 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1bimzelx in patients70.59%
2in patients with70.59%
3patients with a60.51%
4of bimzelx in60.51%
5use of bimzelx40.34%
6us healthcare professionals30.25%
7moderatetosevere plaque psoriasis30.25%
8very first dose30.25%
9and maintained clearance30.25%
10us healthcare professional30.25%
11risks and benefits30.25%
12treatment with bimzelx30.25%
13the very first30.25%
14from the very30.25%
15weeks 0 430.25%
16subcutaneous injections of20.17%
17injections of 16020.17%
18as 2 subcutaneous20.17%
192 subcutaneous injections20.17%
20given as 220.17%
21mg given as20.17%
22320 mg given20.17%
23plaque psoriasis is20.17%
24with moderatetosevere plaque20.17%
25patients with moderatetosevere20.17%
26adult patients with20.17%
27of 160 mg20.17%
28safety profile  through20.17%
29160 mg each20.17%
308 weeks thereafter20.17%

FOUR WORD PHRASES 1238 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1in patients with a60.48%
2bimzelx in patients with60.48%
3of bimzelx in patients50.40%
4use of bimzelx in40.32%
5from the very first30.24%
6clinical relevance of the20.16%
7relevance of the mechanism20.16%
8detailed dosing and results20.16%
9for detailed dosing and20.16%
10page for detailed dosing20.16%
11years6‡ view safety profile20.16%
12information bsabody surface area20.16%
13of the mechanism of20.16%
14moderatetosevere plaque psoriasis is20.16%
15with moderatetosevere plaque psoriasis20.16%
16please see the beforeafter20.16%
17trial please see the20.16%
18patients with moderatetosevere plaque20.16%
19adult patients with moderatetosevere20.16%
20for adult patients with20.16%
21320 mg given as20.16%
22complete and maintained clearance20.16%
23mg given as 220.16%
24the way with image20.16%
25scientific and medical site20.16%
26and medical site patient20.16%
27medical site patient site20.16%
28mg each at weeks20.16%
29160 mg each at20.16%
30of 160 mg each20.16%
31injections of 160 mg20.16%
32clear the way with20.16%
33from the be vivid20.16%
34for bioexperienced patients explore20.16%
35subcutaneous injections of 16020.16%
362 subcutaneous injections of20.16%
37as 2 subcutaneous injections20.16%
38area and severity index20.16%
39pasipsoriasis area and severity20.16%
40given as 2 subcutaneous20.16%

EXTERNAL LINKS

# URL Whois Check
1https://www.ucb.com/Cookie-policy Whoisucb.com
2 https://www.ucb.com/Cookie-policy Whoisucb.com
3 https://www.ucbsavings.com/ Whoisucbsavings.com
4 https://www.ucbcompass.com/ Whoisucbcompass.com
5 https://www.bimzelx.com/ Whoisbimzelx.com
6 https://www.ucbsavings.com/ Whoisucbsavings.com
7 https://www.ucbcompass.com/ Whoisucbcompass.com
8 https://www.bimzelx.com/ Whoisbimzelx.com
9 https://reachmd.com/programs/expert-perspectives-new-treatment-plaque-psoriasis/ Whoisreachmd.com
10 https://www.ucb-usa.com/UCB-in-the-U-S/UCB-in-the-US Whoisucb-usa.com
11 https://www.ucb-usa.com/policy Whoisucb-usa.com
12 https://www.ucb-usa.com/Legal Whoisucb-usa.com
13 https://www.ucb-usa.com/Contact/Contact-Us Whoisucb-usa.com
14 https://mc7d75kvppc8k9gmwryrzhd7fqzm.pub.sfmc-content.com/23qskskaiwo?Brand=Bimzelx&UserType=HCP&Source=Website Whoissfmc-content.com
15 https://www.psoriasis.org/ Whoispsoriasis.org
16 https://www.ucb.com/UCBCares Whoisucb.com
17 https://www.bimzelx.com Whoisbimzelx.com